Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Inventory Average came in at $125000.0 in Q2 2026, up 12475.45% year-over-year from N/an in Q2 2025, and up 12475.45% quarter-over-quarter from $994.0 in Q3 2025.

Analysis

Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Inventory Average for 6 consecutive years, with $125000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Inventory Average rose 12475.45% year-over-year to $125000.0 in Q2 2026; TTM through Jun 2026 was $125000.0, a 12475.45% increase from a year earlier, with the FY2024 full-year figure at $4394.0, down 47.65% from the prior year.
  • Inventory Average was $125000.0 for Q2 2026 at Creative Medical Technology Holdings, up from $994.0 in the prior quarter.
  • Over five years, Inventory Average peaked at $125000.0 in Q2 2026 and troughed at $994.0 in Q2 2025.
  • A 5-year average of $15258.3 and a median of $8094.0 in 2023 frame the typical range for Inventory Average.
  • Across the five-year window, Inventory Average plunged 80.1% in 2025 and soared 12475.45% in 2026, its largest moves.
  • Over 5 years, Inventory Average stood at $13044.0 in 2022, then sank by 44.85% to $7194.0 in 2023, then tumbled by 61.16% to $2794.0 in 2024, then tumbled by 64.42% to $994.0 in 2025, then soared by 12475.45% to $125000.0 in 2026.
  • The last three Inventory Average figures came in at $125000.0 (Q2 2026), $994.0 (Q3 2025), and $994.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 44.10 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 56.98 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 39.30 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn -
6 Beam Therapeutics 3.06 Bn 3.06 Bn - -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 17.49 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 952.69 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 18.37 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 125,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125,000.00
Sep 30, 2025 994.00
Jun 30, 2025 994.00
Mar 31, 2025 1,594.00
Dec 31, 2024 2,794.00
Sep 30, 2024 3,394.00
Jun 30, 2024 4,994.00
Mar 31, 2024 6,594.00
Dec 31, 2023 7,194.00
Sep 30, 2023 8,994.00
Jun 30, 2023 10,194.00
Mar 31, 2023 10,194.00
Dec 31, 2022 13,044.00
Sep 30, 2022 18,259.50
Jun 30, 2022 17,387.50
Mar 31, 2022 12,508.00
Jun 30, 2020 2,000.00